Pharmaceutical Glass Tubing Market globally expected to drive growth through 2027 made by top research firm

Introduction and Need of the Product:

The Glass is the most widely used packaging material for the pharmaceutical industry. Most of the primary packaging products, such as bottles, ampoules, vials, syringes, etc., in the industry are made up of the glass material. Pharmaceutical tubing is used as a raw material by the pharmaceutical packaging companies to manufacture primary packaging products. The glass tubing is supplied by the major international companies such as Corning, Schott, etc. There are four types of glass tubing supplied by the glass manufacturers to packaging manufacturers. The most prominent glass type which is used for pharmaceutical glass packaging is Glass Type I. Type I glass is also known as ‘Borosilicate Glass’, which possesses exceptional chemical stability and high heat resistance to thermal shock and sudden temperature change. For protection from sunlight, Low alkali extractable such as Fe2O3, Ti2O3, or MnO could be added to Type I glass to produce Amber Borosilicate Glass. Type III glass is also known as ‘Soda Lime Glass’ which is used to produce pharmaceutical bottles to store only solid drug products due to their low chemical resistance properties. Pharmaceutical glass tubing plays a major role in the manufacturing process of pharmaceutical parental containers.

Pharmaceutical Glass Tubing Market: Market Dynamics

The pharmaceutical glass tubing market is highly consolidated with the three market players i.e. Corning Pharmaceutical Glass, Schott AG, and Nipro Pharmaceutical Packaging. All of these companies together account for more than 30% market share in the pharmaceutical glass tubing market. Due to high growth in the demand for the pharmaceutical parental packaging products, the pharmaceutical glass tubing market will witness an impressive CAGR of 5%-6% in the next 6-7 years. However, it is little difficult for the new entrants to capture significant market share in the market due to the predominance of few players. Companies present in the market are planning to invest in the developing countries such as China, India, etc. to strengthen their supply chain and serve new customers in the market. Glass is the still the widely preferred format for the manufacturing of the pharmaceutical parental packaging containers. However, plastics materials are gaining traction in the production of the pharmaceutical syringes but plastics material still accounts for less than 20% of the global syringes market. Glass delamination is the major problem noticed in the pharmaceutical glass packaging market which may decrease its demand to some extent in the near future.

Request to Sample of Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-6582

Some of the key developments observed in the pharmaceutical glass tubing market are:

In November 2017, Schott AG has started a new manufacturing facility in the China to manufacture ampoules, vials and cartridges made of glass tubing for the domestic pharma industry.

In January 2017, Schott AG has integrated a specially developed big data solution in its glass tubing manufacturing facility to improve quality standards.

In November 2015, Corning Incorporated completed the acquisition of the Gerresheimer’s Pharmaceutical Glass Tubing Business for US$ 242 Mn.

Pharmaceutical Glass Tubing Market: Regional Overview

On the basis of region, the Pharmaceutical Glass Tubing market is segmented into seven regions which include North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, Middle East & Africa, and Japan. The North America and Europe dominate the pharmaceutical glass tubing market due to high presence of the tubing manufacturers and pharmaceutical companies in the region. Companies such as Schott, Nipro, etc. account for significant market share and hold dominant position in the market. It has been observed that the sales revenue of these companies has increased at a good rate in the last few years which reflects a high growth in the market. Asia-Pacific region accounts for the third-most dominant region in the global pharmaceutical glass tubing market. Also, prominent companies are shifting their focus to invest in the developing markets to significantly gain market share in those regions. MEA and Japan also offer untapped growth potential in the global pharmaceutical glass tubing market.

Request Report for Table of Contents @ https://www.futuremarketinsights.com/toc/rep-gb-6582

Pharmaceutical Glass Tubing Market: Market Players

Some of the key players in the Pharmaceutical Glass Tubing market are Schott AG, Nipro Pharma Corporation, Corning Incorporated, Nippon Electric Glass Co., Ltd., Accu-Glass LLC., Richland Glass Co., Inc., Cang Zhou Four-star Glass Co.,Ltd., LINUO Group, DWK Life Sciences GmbH, Puyang New Harmony Industrial Development Co., LTD, Shandong Pharmaceutical Glass Co, Ltd.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. 

Report Highlights : Detailed overview of parent market,Changing market dynamics in the industry,In-depth market segmentation,Historical, current and projected market size in terms of volume and value,Recent industry trends and developments,Competitive landscape,Strategies of key players and products offered,Potential and niche segments, geographical regions exhibiting promising growth,A neutral perspective on market performance,Must-have information for market players to sustain and enhance their market footprint.

Request to Report Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-6582

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: www.futuremarketinsights.com

This release was published on openPR.